ライフサイエンスコーパス: Staphylococcus

1 culture positivity was 48.6%, most commonly Staphylococcus.

2 is (2 Candida glabrata, 2 coagulase-negative Staphylococcus, 1 Streptococcus pneumoniae).

3 Staphylococcus (403/950, 42.4%) and streptococcus (337/9

4 encoding orthologous proteins from the genus Staphylococcus and found that mRNA conservation was lost

5 se is associated with increased abundance of Staphylococcus and Streptococcus in the lungs, yet their

6 ory cultures, the most common pathogens were Staphylococcus aureus (34%) and Pseudomonas aeruginosa (

7 The targets with a PPA of <100% were Staphylococcus aureus (34/37 [91.9%]), Streptococcus pne

8 e incident PJI was most frequently caused by Staphylococcus aureus (43%), followed by streptococci (2

9 Streptococcus pneumoniae (9/44 [20%]) and Staphylococcus aureus (7/14 [50%]) were the predominant

10 ved among patients with pneumonias caused by Staphylococcus aureus (90-day multivariable adjusted OR,

11 Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is threatening public he

12 h community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) SSTI, their household co

13 e were inoculated with methicillin-resistant Staphylococcus aureus (MRSA) and a Kirschner wire (K-wir

14 vitro activity against methicillin-resistant Staphylococcus aureus (MRSA) and bolsters the innate imm

15 Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile i

16 tant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and other healthcare-associ

17 CCN1 opsonizes methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa

18 Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated wi

19 comes in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.

20 erial activity against methicillin-resistant Staphylococcus aureus (MRSA) bacterial strain.

21 ted to be effective in Methicillin-resistant Staphylococcus aureus (MRSA) elimination.

22 d minimize toxicity in methicillin-resistant Staphylococcus aureus (MRSA) for various infections, the

23 enomic surveillance of methicillin-resistant Staphylococcus aureus (MRSA) identifies unsuspected tran

24 , we isolated EVs from methicillin-resistant Staphylococcus aureus (MRSA) in an environment with or w

25 y facilitate spread of methicillin-resistant Staphylococcus aureus (MRSA) in urban areas.

26 Methicillin-resistant Staphylococcus aureus (MRSA) infections cause significan

27 vention and control of methicillin-resistant Staphylococcus aureus (MRSA) infections remain challengi

28 ately needed to combat methicillin-resistant Staphylococcus aureus (MRSA) infections.

29 Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of health

30 Treatment of suspected methicillin-resistant Staphylococcus aureus (MRSA) is a cornerstone of many an

31 Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of ve

32 n networks.We examined methicillin-resistant Staphylococcus aureus (MRSA) isolates to determine if th

33 treatments in killing methicillin-resistant Staphylococcus aureus (MRSA) persisters.

34 ption of high facility methicillin-resistant Staphylococcus aureus (MRSA) prevalence-not MRSA coloniz

35 e and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains poses a major threa

36 ted emergence of novel methicillin resistant Staphylococcus aureus (MRSA) strains.

37 gene cycA resensitized methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics.

38 Live methicillin-resistant Staphylococcus aureus (MRSA) was inoculated into the tai

39 rial pathogens such as methicillin-resistant Staphylococcus aureus (MRSA)(1-3).

40 ococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enter

41 584) were surveyed for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enter

42 t infections caused by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enter

43 e primarily focused on methicillin-resistant Staphylococcus aureus (MRSA).

44 bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA).

45 rly deescalation for methicillin-susceptible Staphylococcus aureus (MSSA) (19/24 [79%]) and avoidance

46 ditis) of persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, including immed

47 tic-resistant species [methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant Stap

48 Staphylococcus aureus (S. aureus) is a common colonizer

49 eting the femA or lytA gene for detection of Staphylococcus aureus (S. aureus) or Streptococcus pneum

50 ethod against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), which decreased first

51 ed that the adaptive immune response against Staphylococcus aureus (SA) skin infection substantially

52 Testing of staphylococci other than Staphylococcus aureus (SOSA) for mecA-mediated resistanc

53 microbial agents, anti-methicillin-resistant Staphylococcus aureus [anti-MRSA] agents, and antipseudo

54 Staphylococcus aureus adhesion to the host's skin and mu

55 in hypertension, glaucoma, and responses to Staphylococcus aureus alpha-toxin.

56 etection of the pathogenic bacterial species Staphylococcus aureus and antibiotic resistant Acinetoba

57 to interrogate the morphologically distinct Staphylococcus aureus and Bacillus subtilis species, usi

58 Staphylococcus aureus and Enterobacterales were the most

59 observed in less than half of patients, with Staphylococcus aureus and enterococcus bacteremia associ

60 Staphylococcus aureus and enterococcus had the highest 1

61 In IE cases treated with valve surgery, Staphylococcus aureus and Enterococcus spp. were associa

62 n of multidrug-resistant bacteria, including Staphylococcus aureus and Escherichia coli, leading to t

63 Unit-level changes in methicillin-resistant Staphylococcus aureus and extended-spectrum beta lactama

64 blood mononuclear cells were stimulated with Staphylococcus aureus and Mycobacterium tuberculosis bef

65 t attach virulence factors to the surface of Staphylococcus aureus and other medically significant ba

66 ly with their antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa and wit

67 Staphylococcus aureus and Pseudomonas aeruginosa were is

68 is essential for fatty acid biosynthesis in Staphylococcus aureus and represents a promising target

69 The most common implicated pathogens were Staphylococcus aureus and S. epidermidis.

70 Staphylococcus aureus and Staphylococcus epidermidis are

71 spp., Escherichia coli, Salmonella enterica, Staphylococcus aureus and Streptococcus pneumoniae were

72 rate the sensor's specificity, tests against Staphylococcus aureus and Streptococcus uberis samples a

73 omodulatory RNA and DNA by pathogens such as Staphylococcus aureus and their delivery to intracellula

74 socomial pathogenic microorganisms including Staphylococcus aureus and two Candida strains.

75 th decreased capacity of neutrophils to kill Staphylococcus aureus and worse clinical outcomes.

76 ted bacterial clearance after infection with Staphylococcus aureus and, by licensing encephalitogenic

77 Moreover, after epicutaneous Staphylococcus aureus application, impaired S1pr2(-/-) m

78 Pseudomonas aeruginosa and Staphylococcus aureus are opportunistic bacterial pathog

79 22.8%) cultured SSTIs, 332 (66.0%) recovered Staphylococcus aureus as a pathogen, of which 287/332 (8

80 ocidin (Luk) exotoxins of the major pathogen Staphylococcus aureus as a prototype, we randomly fragme

81 of 0.024 ug/mL against methicilin resistant Staphylococcus aureus ATCC 43300 and Candida albicans MT

82 Staphylococcus aureus bacteraemia (SAB) is associated wi

83 ctive, matched cohort study of patients with Staphylococcus aureus bacteremia (SAB) and gram-negative

84 Staphylococcus aureus bacteremia (SaB) causes significan

85 Persistent Staphylococcus aureus bacteremia (SAB) is defined based

86 Staphylococcus aureus bacteremia (SAB) is uniquely chara

87 itis (IE) is the most feared complication of Staphylococcus aureus bacteremia (SAB).

88 e skin and skin structure infections (SSSI), Staphylococcus aureus bacteremia, and right-sided endoca

89 Understanding the changing epidemiology of Staphylococcus aureus bacteremia, as well as the variabl

90 ptic shock and 2) hospitalized patients with Staphylococcus aureus bacteremia.

91 eudomonas aeruginosa and Gram stain-positive Staphylococcus aureus bacteria, inducing 95 +/- 5% and 8

92 etiologic agent, the Gram-positive bacterium Staphylococcus aureus Bacterial osteomyelitis triggers p

93 ss than 1 mum diameter) and nearly spherical Staphylococcus aureus bacterium.

94 y examined antibody-based assays against the Staphylococcus aureus biofilm-upregulated antigens SAOCO

95 The virulence mechanisms associated with Staphylococcus aureus biofilms are becoming better under

96 m activity of D-Asp and D-Glu was studied on Staphylococcus aureus biofilms.

97 sessed the association of Community acquired Staphylococcus aureus bloodstream infection (CA-SABSI) w

98 apeutic approaches are critically needed for Staphylococcus aureus bloodstream infections (BSIs), par

99 Selection pressures exerted on Staphylococcus aureus by host factors during infection m

100 t Escherichia coli and methicillin-resistant Staphylococcus aureus by recognizing corresponding antim

101 ker-attached trisaccharide repeating unit of Staphylococcus aureus capsular polysaccharide type 5, wh

102 This study investigated Staphylococcus aureus carriage in patients with microbia

103 CRISPR-Staphylococcus aureus Cas9 (CRISPR-SaCas9) has been harn

104 To identify Acrs capable of inhibiting Staphylococcus aureus Cas9 (SauCas9), an alternative to

105 manner using wild-type Escherichia coli and Staphylococcus aureus cells at variable levels of target

106 cteria, including 8/60 (13.3%) patients with Staphylococcus aureus Chronic tissue infection with S. a

107 py in dairy cows with experimentally induced Staphylococcus aureus clinical mastitis.

108 To determine the effects of dupilumab on Staphylococcus aureus colonization and microbial diversi

109 and adhesin genes, which, in turn, promotes Staphylococcus aureus colonization.

110 isition system in the opportunistic pathogen Staphylococcus aureus comprises nine proteins, called ir

111 tection (316 copies of methicillin-resistant Staphylococcus aureus DNA) in our lab's "MD NAAT" platfo

112 Staphylococcus aureus fatty acid kinase FakA is necessar

113 roach is sensitive to detecting as few as 17 Staphylococcus aureus genomes from a background of 100 n

114 ology of the major human and animal pathogen Staphylococcus aureus has been greatly enhanced by techn

115 ificity produced by the pathogenic bacterium Staphylococcus aureus identifies two positions that cont

116 Members of the EAP family of Staphylococcus aureus immune evasion proteins potently i

117 target in 117/200 (58.5%) samples, including Staphylococcus aureus in 22% of samples and Haemophilus

118 or gammadelta T cells to mediate immunity to Staphylococcus aureus in multiple tissue settings by the

119 The detection of Staphylococcus aureus in the concentration range from 50

120 and, finally, on the role of eosinophils and Staphylococcus aureus in the persistence of disease.

121 ed healing in ischemic methicillin-resistant Staphylococcus aureus infected delayed healing wounds in

122 study have identified an association between Staphylococcus aureus infection and acute myocardial inf

123 as been implicated in host defense following Staphylococcus aureus infection, but precise mechanisms

124 ong all IE-SUD hospitalizations, 50.3% had a Staphylococcus aureus infection, compared with 19.4% of

125 in increased inflammation and mortality upon Staphylococcus aureus infection, recapitulating the huma

126 and a reduction in swarm formation following Staphylococcus aureus infection.

127 one marrow that is most commonly caused by a Staphylococcus aureus infection.

128 ds demonstrated cidality in a mouse model of Staphylococcus aureus infection.

129 Staphylococcus aureus infections can lead to diseases th

130 increased owing to a surge in drug-resistant Staphylococcus aureus infections, both in the hospital a

131 ng treated for serious methicillin-resistant Staphylococcus aureus infections.

132 Staphylococcus aureus is a common pathogen causing infec

133 Staphylococcus aureus is a Gram-positive bacterium respo

134 Staphylococcus aureus is a Gram-positive opportunistic p

135 Staphylococcus aureus is a leading cause of bacterial pn

136 Staphylococcus aureus is a leading cause of biofilm-asso

137 Staphylococcus aureus is a leading cause of biofilm-asso

138 Staphylococcus aureus is a leading cause of health care-

139 Staphylococcus aureus is a leading cause of healthcare-

140 Staphylococcus aureus is a leading cause of pneumonia.

141 Staphylococcus aureus is a major human pathogen that cau

142 Staphylococcus aureus is a major human pathogen, and the

143 heat-shock GTPase HflX in the human pathogen Staphylococcus aureus is a minor disassembly factor.

144 Staphylococcus aureus is a significant human pathogen du

145 Staphylococcus aureus is also a "high priority" pathogen

146 Staphylococcus aureus is among the leading causes of bac

147 Staphylococcus aureus is an extremely infectious and mal

148 Staphylococcus aureus is an important bacterial pathogen

149 Staphylococcus aureus is an important human bacterial pa

150 Staphylococcus aureus is an opportunistic pathogen that

151 Moreover, we show that relative abundance of Staphylococcus aureus is associated with disease severit

152 The bacterial pathogen Staphylococcus aureus is capable of infecting a broad sp

153 Staphylococcus aureus is generally thought to divide in

154 Staphylococcus aureus is one of the four most prevalent

155 Staphylococcus aureus is responsible for various disease

156 Examples including Staphylococcus aureus isolates, gut metagenomes, and met

157 Staphylococcus aureus lacking this protease is attenuate

158 n addition, we found that IL-4 and IL-13 and Staphylococcus aureus lipoteichoic acid work in combinat

159 H and skin microbiome dysbiosis, due to high Staphylococcus aureus loads, especially during flares.

160 ntimicrobial activity against multiresistant Staphylococcus aureus MIC = 5 mg/mL) and no cytotoxicity

161 tly reduce bacterial loads in a high-density Staphylococcus aureus murine skin infection model.

162 Here, we study the Staphylococcus aureus NanK (SaNanK), which is the first

163 Clinically important Staphylococcus aureus obtains iron by extracting heme fr

164 ts relationship with the nicking activity of Staphylococcus aureus plasmid pT181 initiator RepC.

165 Infections caused by Staphylococcus aureus pose a serious and sometimes fatal

166 Staphylococcus aureus relies on quorum sensing to exert

167 Staphylococcus aureus remains a leading cause of human i

168 Here we describe the binding mode of Staphylococcus aureus RsfS to the large ribosomal subuni

169 in vivo that early activation of Treg during Staphylococcus aureus sepsis induces CD4+ T-cell impairm

170 emolysin is critical for the pathogenesis of Staphylococcus aureus skin and soft tissue infection.

171 sex differences in innate susceptibility to Staphylococcus aureus skin infection and that bone marro

172 Staphylococcus aureus small colony variants (SCVs) are f

173 e evaluated the use of different variants of Staphylococcus aureus sortase A for a range of ligation

174 c activity of chromate reductase, NfoR, from Staphylococcus aureus sp. LZ-01 was augmented 1.5-fold b

175 Staphylococcus aureus ST45 is a major global MRSA lineag

176 A Staphylococcus aureus strain deleted for the c-di-AMP cy

177 ers to analyze the phage-host interaction of Staphylococcus aureus strain FS159 with a virulent phage

178 ity was evaluated against the multiresistant Staphylococcus aureus strain USA300 for which they displ

179 a community-associated methicillin-resistant Staphylococcus aureus strain were internalized into huma

180 secretion system (T7SS) is conserved across Staphylococcus aureus strains and plays important roles

181 Staphylococcus aureus strains carrying enterotoxin A gen

182 Staphylococcus aureus strains showing higher relative bi

183 ated the utility of the Python package using Staphylococcus aureus strains that are resistant to vari

184 lytic activity of Cd-SrtB and also SrtB from Staphylococcus aureus The serine residue indispensable f

185 orter, PstSCAB, increases the sensitivity of Staphylococcus aureus to calprotectin-mediated manganese

186 The Staphylococcus aureus type VII secretion system (T7SS) e

187 , Streptococcus pneumoniae serotype 12F, and Staphylococcus aureus types 5 and 8 capsular polysacchar

188 Here, we analyze genomic sequences of Staphylococcus aureus USA300 isolates from the same geog

189 Staphylococcus aureus was the most common pathogen (53%)

190 bacterial 14TM helix transporter, NorC, from Staphylococcus aureus We identified this antibody in a y

191 Among Gram-positive bacteria, Staphylococcus aureus were predominant.

192 challenging a diverse set of 222 isolates of Staphylococcus aureus with the antibiotic ciprofloxacin

193 observation of intracellular localization of Staphylococcus aureus within mast cells in nasal polyps.

194 n model with heat-inactivated Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia co

195 a or bacterial (Streptococcus pneumoniae and Staphylococcus aureus) etiologies and compared with heal

196 t Escherichia coli and methicillin-resistant Staphylococcus aureus).

197 domonas fluorescens, Salmonella typhimurium, Staphylococcus aureus); and fungal enzymes under acid-st

198 ree urgent threat pathogens encompassing 288 Staphylococcus aureus, 456 Pseudomonas aeruginosa, and 1

199 e pathogens, including methicillin-resistant Staphylococcus aureus, a common cause of human infection

200 uppresses its antimicrobial activity against Staphylococcus aureus, a common pathogen co-isolated wit

201 nterobacter agglomerans, Pseudomonas putida, Staphylococcus aureus, and Bacillus subtilis was observe

202 and saliva) and bacteria media (blank broth, Staphylococcus aureus, and E. coli).

203 pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli We have prev

204 ogens, including Mycobacterium tuberculosis, Staphylococcus aureus, and Escherichia coli, and identif

205 ed the risk of EOS by group B Streptococcus, Staphylococcus aureus, and Escherichia coli.

206 Cas9 nucleases from Streptococcus pyogenes, Staphylococcus aureus, and Francisella novicida complexe

207 titis (AD) patients are often colonized with Staphylococcus aureus, and staphylococcal biofilms have

208 , including major clinical pathogens such as Staphylococcus aureus, are becoming increasingly drug-re

209 d cells showed defective in vitro killing of Staphylococcus aureus, consistent with a specific granul

210 t several streptogramin-resistant strains of Staphylococcus aureus, exhibits decreased rates of acety

211 be infected with Chlamydophila pneumoniae or Staphylococcus aureus, have received antibacterial drug

212 Multi-drug resistant Staphylococcus aureus, including methicillin-resistant S

213 The Gram-positive bacterium, Staphylococcus aureus, is a versatile pathogen that can

214 Staphylococcus aureus, known to induce IFN production, c

215 In Staphylococcus aureus, pentaglycine cross-bridges are sy

216 When applied to wild-type Staphylococcus aureus, PETRI-seq revealed a rare subpopu

217 ts and Main Results: Haemophilus influenzae, Staphylococcus aureus, Pseudomonas aeruginosa, and Asper

218 PSOP displayed inhibitory activity against Staphylococcus aureus, Pseudomonas aeruginosa, and Enter

219 er, as well as its evaluation in PDI against Staphylococcus aureus, Pseudomonas aeruginosa, and Esche

220 not part of routine empiric coverage (e.g., Staphylococcus aureus, Pseudomonas aeruginosa, Clostridi

221 ective ability of the opportunistic pathogen Staphylococcus aureus, recognized as the most frequent c

222 del membranes and Pseudomonas aeruginosa and Staphylococcus aureus, representing Gram-positive and Gr

223 Most other bacterial pathogens, including Staphylococcus aureus, secrete numerous toxins and evolv

224 ter baumannii, Stenotrophomonas maltophilia, Staphylococcus aureus, Staphylococcus epidermidis and St

225 In Staphylococcus aureus, the peptidoglycan assembly enzyme

226 o achieve effective tools that fight against Staphylococcus aureus, the results have not been success

227 In Staphylococcus aureus, the transcription factor CodY mod

228 erium tuberculosis, Salmonella enterica, and Staphylococcus aureus, we report that it is possible to

229 (LukED) is a pore-forming toxin produced by Staphylococcus aureus, which lyses host cells and promot

230 hia coli (UPEC), Pseudomonas aeruginosa, and Staphylococcus aureus, with up to 3.7 logs of biomass re

231 In Staphylococcus aureus-caused endocarditis, the pathogen

232 hile ex vivo Mycobacterium tuberculosis- and Staphylococcus aureus-induced cytokine responses in peri

233 stridium difficile and methicillin-resistant Staphylococcus aureus.

234 uman pathogens such as methicillin-resistant Staphylococcus aureus.

235 teria monocytogenes, Salmonella enterica and Staphylococcus aureus.

236 a of the reduced colonisation of implants by Staphylococcus aureus.

237 O had an antimicrobial activity against only Staphylococcus aureus.

238 ions of S100A8 or subcutaneous injections of Staphylococcus aureus.

239 nds were infected with methicillin-resistant Staphylococcus aureus.

240 as community-acquired methicillin-resistant Staphylococcus aureus.

241 for infections due to methicillin-resistant Staphylococcus aureus.

242 roduction in Group B Streptococcus (GBS) and Staphylococcus aureus.

243 bacter baumanii, Pseudomonas aeruginosa, and Staphylococcus aureus.

244 o have activity against Escherichia coli and Staphylococcus aureus.

245 infarction 365 days after blood culture for Staphylococcus aureus.

246 h community-associated methicillin-resistant Staphylococcus aureus.

247 cation characteristic for the human pathogen Staphylococcus aureus.

248 PiuA functions in the same way as SstD from Staphylococcus aureus.

249 ffender isolated from the PLA in children is Staphylococcus aureus.

250 um tuberculosis, Pseudomonas aeruginosa, and Staphylococcus aureus.

251 hese were extracts of Zanthoxylum chalybeum (Staphylococcus aureus: MIC: 16 mug/mL; Enterococcus faec

252 es and identified a small Cas9 ortholog from Staphylococcus auricularis (SauriCas9), which recognizes

253 onounced in patients with coagulase negative Staphylococcus bacteremia (5.5d and 4.5d vs 7.2d; P=0.00

254 e positive in 41.6%, with coagulase-negative Staphylococcus being the most common bacteria identified

255 cs, and proteomics we discovered a strain of Staphylococcus capitis (S. capitis E12) that selectively

256 The multidrug-resistant Staphylococcus capitis NRCS-A clone is responsible for s

257 Isolates of Staphylococcus capitis, Staphylococcus haemolyticus, Sta

258 ions for over 60 days and continue to resist Staphylococcus colonization.

259 the 4 microbiome trajectories identified, a Staphylococcus-dominant microbiome in the first 6 months

260 ensing gate for the early stage detection of Staphylococcus epidermidis (S. epidermidis) biofilm form

261 positive Enterococcus durans (E. durans) and Staphylococcus epidermidis (S. epidermidis) by PAA combi

262 tuf gene for detection and quantification of Staphylococcus epidermidis (S. epidermidis).

263 rthopedic device-related infection caused by Staphylococcus epidermidis and four different Cutibacter

264 phomonas maltophilia, Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus pyogenes in

265 Many strains of Staphylococcus epidermidis are capable of forming biofil

266 Staphylococcus aureus and Staphylococcus epidermidis are the most abundant bacteri

267 mproved in vitro dispersal of PNAG-dependent Staphylococcus epidermidis biofilms.

268 ll GLP-1 positive strains were identified as Staphylococcus epidermidis by 16S rRNA sequencing.

269 Visual outcomes of Staphylococcus epidermidis endophthalmitis were no diffe

270 The Staphylococcus epidermidis glucose/H(+) symporter (GlcP(

271 e accumulation-associated protein (Aap) from Staphylococcus epidermidis is a biofilm-related protein

272 mentally inoculated with Enterobacteriaceae, Staphylococcus epidermidis or Staphylococcus hominis yie

273 e structural and biochemical features of two Staphylococcus epidermidis RNase J paralogs, RNase J1 an

274 ry trajectory and functional distribution of Staphylococcus epidermidis-a keystone skin microbe and o

275 adulthood, with an increase of the commensal Staphylococcus epidermidis.

276 nsing (QS) receptor in the emerging pathogen Staphylococcus epidermidis.

277 in Listeria, Enterococcus, Streptococcus and Staphylococcus genomes, can inhibit type II-A SpyCas9 or

278 Isolates of Staphylococcus capitis, Staphylococcus haemolyticus, Staphylococcus hominis, and

279 obacteriaceae, Staphylococcus epidermidis or Staphylococcus hominis yielded hydrogen, but no methane,

280 coccus capitis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus warneri were

281 Another commensal skin bacterial species, Staphylococcus hominis, can inhibit EcpA production by S

282 in the Western world, whereas the number of Staphylococcus infection-associated glomerulonephritis (

283 These Staphylococcus infections range from superficial skin in

284 view highlights the ability of Enterococcus, Staphylococcus, Klebsiella, Acinetobacter, Pseudomonas,

285 Lha in the opportunistic bacterial pathogen Staphylococcus lugdunensis and show that the transporter

286 Here, we report that Staphylococcus nepalensis releases corisin, a peptide co

287 Although most cultures yielded no growth, no Staphylococcus or gram-negative growth was found for pat

288 Driveline smears revealed Staphylococcus or Pseudomonas strains as the underlying

289 Specific viral taxa, such as Staphylococcus phages and Herpesviridae, were associated

290 antly associated with Enterobacteriaceae and Staphylococcus, siderophore-like BGCs can be identified

291 ere tested against R. solanacearum, E. coli, Staphylococcus sp. and B. subtilis, and exhibited activi

292 Escherichia coli and Staphylococcus sp. isolates were also inhibited by Bacil

293 The most common pathogens were Staphylococcus species (60%) and Streptococcus species (

294 es, individual-specific outlier abundance of Staphylococcus species (eg, S epidermidis, S capitis, S

295 n this study, Burkholderia, Pseudomonas, and Staphylococcus species were isolated from the sputum of

296 o 9.84; p = 0.003) for Enterococcus spp. and Staphylococcus spp., respectively.

297 ore microbiome comprised of Corynebacterium, Staphylococcus, Streptococcus, Haemophilus and Moraxella

298 is arguably the most important regulator of Staphylococcus virulence.

299 us haemolyticus, Staphylococcus hominis, and Staphylococcus warneri were evaluated by cefoxitin and o

300 icrobial diversity and relative abundance of Staphylococcus were assessed by DNA sequencing of 16S ri